ly3437943 retatrutide triple agonist glp-1 gip glucagon mechanism A review of an investigational drug retatrutide, a novel agent for the treatment of A once-daily GLP-1/GIP/glucagon receptor tri-agonist
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16


























